GeneDx Holdings Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by GeneDx Holdings Corp. on June 18, 2026. The filing details the voting results for four proposals submitted to shareholders. The record date for the meeting was April 20, 2026, with 29,675,547 shares of Class A common stock issued and outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes.
Material Changes and Voting Results
All four proposals presented at the Annual Meeting were approved by the stockholders. The specific voting results were as follows:
- Proposal 1 (Director Election): Katherine Stueland was elected as a Class II director for a three-year term. She received 18,325,894 votes for, with 5,893,466 votes withheld and 3,409,327 broker non-votes.
- Proposal 2 (Auditor Ratification): Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes were 27,466,639 for, 158,884 against, and 3,164 abstentions.
- Proposal 3 (Executive Compensation): The advisory vote on executive compensation was approved with 22,705,946 votes for, 1,471,593 against, and 41,821 abstentions.
- Proposal 4 (Compensation Vote Frequency): Stockholders indicated a preference for future advisory votes on executive compensation to be held annually (every one year). Votes were 23,816,121 for 1 year, 24,246 for 2 years, 358,017 for 3 years, and 20,976 abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the results of the shareholder vote.
Key Facts for Investor Verification
- Verify the full details of the Director Election and the background of the newly elected Class II director, Katherine Stueland.
- Confirm the engagement terms and fees for Ernst & Young LLP as the newly ratified auditor for fiscal year 2026.
- Review the Definitive Proxy Statement on Schedule 14A (filed April 30, 2026) for detailed executive compensation data referenced in Proposal 3.
- Note the shareholder preference for annual say-on-pay votes, which may influence future governance policies.